Monetizing Sovereign and ISDS Arbitral Awards

How the ICSID Convention, the New York Convention, and sovereign immunity doctrine shape the market for buying an interest in an award against a state.

Why does monetizing an award against a sovereign state differ from monetizing a commercial award? Because a state respondent can raise sovereign immunity defenses a private commercial debtor cannot, and because the two principal treaty frameworks governing these awards, the ICSID Convention and the New York Convention, impose meaningfully different enforcement mechanics that a purchaser must evaluate before pricing an interest in the award.

Investor-state dispute settlement awards rendered under the ICSID Convention benefit from Article 54, which requires each contracting state to recognize an ICSID award as binding and enforce the pecuniary obligations it imposes as if it were a final judgment of that state's own courts, without the merits-review grounds for refusal that apply to awards enforced under the New York Convention. This makes ICSID awards, in principle, easier to enforce once rendered, though Article 54 enforcement can still be complicated by a state's own sovereign immunity from execution against particular categories of its assets, a separate question from the recognition of the award itself.

Commercial arbitral awards, and ISDS awards rendered outside the ICSID framework, are typically enforced under the 1958 Convention on the Recognition and Enforcement of Foreign Arbitral Awards — the New York Convention — which is in force in more than 170 states and permits recognition and enforcement subject to a limited, enumerated set of grounds for refusal, such as invalidity of the arbitration agreement or a violation of public policy in the enforcing state. Because enforcement proceeds country by country under each signatory's own procedures, a purchaser evaluating monetization of an award against a state, or a state-owned entity, must assess enforceability across each jurisdiction where the debtor is believed to hold reachable assets, not just under a single treaty framework.

Sovereign immunity from execution is the most consequential legal obstacle specific to awards against states. In the United States, the Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1602–1611, generally immunizes a foreign state's property from attachment and execution except under narrow statutory exceptions, including property used for commercial activity in the United States and certain arbitration-related exceptions. Purchasers underwriting a sovereign award therefore focus heavily on identifying specific categories of the state's commercial assets that fall within an applicable immunity exception, since a valid, enforceable award is worth little if no reachable, non-immune asset can actually be attached against it.

Pricing an interest in a sovereign or ISDS award reflects this layered risk: the award's finality and any pending annulment proceeding under the ICSID Convention's own annulment framework, the applicable enforcement treaty, the specific states where assets are believed to exist, and the immunity analysis applicable in each — a materially more complex diligence process than pricing an interest in a domestic commercial judgment against a private, non-sovereign defendant.

An award holder exploring monetization typically prepares a documentation package covering the award itself, the current procedural posture of any pending annulment or set-aside proceeding, and whatever information is available about the respondent state's commercial assets and activities in jurisdictions where enforcement might realistically be pursued. Because the ICSID Convention's own annulment mechanism allows a limited set of grounds for challenging an award after it is rendered, a purchaser's diligence gives particular weight to whether an annulment application has actually been filed, since a pending annulment proceeding introduces a distinct timing and finality risk on top of the underlying enforcement analysis, separate from the immunity and asset-location questions discussed above.

Purchasers structuring a monetization transaction typically evaluate several structures rather than a single template: a full assignment of the award in exchange for an upfront payment, a partial monetization that leaves the award holder with a share of eventual proceeds above a defined threshold, or a staged structure where a larger payment is triggered once a specific milestone — such as the resolution of a pending annulment application — has passed. The choice among these structures often reflects how much of the finality and asset-location risk the award holder wants to transfer immediately versus retain in exchange for potential upside if enforcement ultimately proves more successful than the initial pricing assumed.

Because identifying a state's reachable commercial assets across multiple jurisdictions is itself a specialized undertaking, purchasers evaluating sovereign and ISDS awards frequently engage the same category of asset-tracing expertise used in judgment enforcement finance more generally, adapted to the specific immunity frameworks that apply to a sovereign or state-owned respondent rather than a private commercial debtor. Award holders considering monetization should expect this asset-location diligence, not the validity of the award itself, to be the most time-intensive part of the underwriting process, since the award's validity has typically already been established through the arbitration itself.

Because a state's commercial asset footprint in any given jurisdiction can change over time — assets are sold, moved, or newly acquired, and a state's use of a particular property for commercial versus sovereign purposes can itself shift — purchasers holding a monetized interest in an award typically maintain ongoing monitoring of the debtor state's activity in the jurisdictions where enforcement is being pursued, rather than treating the asset-location diligence performed at the time of purchase as a static, one-time picture. This monitoring function is a meaningful part of what distinguishes active management of a sovereign enforcement position from a passive investment, and award holders considering a partial or staged monetization structure should expect the purchaser to factor the cost and complexity of this ongoing monitoring into how the transaction is priced.

Sources: ICSID Convention, Article 54 (recognition and enforcement of awards); Convention on the Recognition and Enforcement of Foreign Arbitral Awards (New York Convention, 1958); Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1602–1611.

Criterica Capital evaluates sovereign and ISDS award monetization opportunities with attention to the applicable enforcement treaty, the annulment posture of the award, and a jurisdiction-specific sovereign immunity and asset analysis before preparing any transaction for independent capital providers. Award holders considering monetization can contact our institutional team for a confidential assessment.

Discuss your matter with our institutional team.